Peng, J., Li, W., Fan, W., Zhou, W., Zhu, Y., Li, X., . . . Lin, J. (2020). Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer. Front Pharmacol.
Stile di citazione ChicagoPeng, Jianhong, Weihao Li, Wenhua Fan, Wenhao Zhou, Ying Zhu, Xueying Li, Zhizhong Pan, Xiaoping Lin, e Junzhong Lin. "Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer." Front Pharmacol 2020.
Citazione MLAPeng, Jianhong, et al. "Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer." Front Pharmacol 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.